300357 Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.
Closed 12-23 15:00:00
21.27
-0.39
-1.80%
High
21.70
Low
21.23
Vol
4.59M
Open
21.65
D1 Closing
21.66
Amplitude
2.17%
Mkt Cap
11.15B
Tradable Cap
10.29B
Total Shares
524.00M
T/O
98.57M
T/O Rate
0.95%
Tradable Shares
484.00M
P/B
4.8
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Zhejiang Wolwo Bio-Pharmaceutical's Q3 Profit Rises 1%
MT Newswires Live · 10-24
Zhejiang Wolwo Bio-Pharmaceutical's Q3 Profit Rises 1%
Chinese Drug Regulator Accepts Wolwo Bio-Pharmaceutical's Application to Test House Dust Mite Film
MT Newswires Live · 09-27
Chinese Drug Regulator Accepts Wolwo Bio-Pharmaceutical's Application to Test House Dust Mite Film
Load more
Introduction
Company Name.
浙江我武生物科技股份有限公司
Industry:
医药制造业
Listing Date:
2014-01-21
Main Business:
浙江我武生物科技股份有限公司是一家过敏性疾病诊断及治疗产品的研发、生产和销售的高新技术企业。公司主要产品包括粉尘螨滴剂、黄花蒿花粉变应原舌下滴剂、粉尘螨皮肤点刺诊断试剂盒、屋尘螨皮肤点刺诊断试剂盒、“黄花蒿花粉变应原皮肤点刺液”、“白桦花粉变应原皮肤点刺液”、“葎草花粉变应原皮肤点刺液”。
Issue price:
20.05
{"stockData":{"symbol":"300357","market":"SZ","secType":"STK","nameCN":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.","latestPrice":21.27,"timestamp":1734937428000,"preClose":21.66,"halted":0,"volume":4594542,"delay":0,"changeRate":-0.018,"floatShares":484000000,"shares":524000000,"eps":0.5965,"marketStatus":"Closed","change":-0.39,"latestTime":"12-23 15:00:00","open":21.65,"high":21.7,"low":21.23,"amount":98566200,"amplitude":0.0217,"askPrice":21.29,"askSize":1,"bidPrice":21.27,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.5965,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1735003800000},"marketStatusCode":5,"adr":0,"adjPreClose":21.66,"symbolType":"stock","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":23.83,"lowLimit":19.49,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":523584000,"isCdr":false,"pbRate":4.8,"roa":"--","peRate":35.658005,"roe":"11.95%","epsLYR":0.5924,"committee":0.644788,"marketValue":11137000000,"turnoverRate":0.0095,"status":1,"floatMarketCap":10296000000},"requestUrl":"/m/hq/s/300357","defaultTab":"news","newsList":[{"id":"2477799935","title":"Zhejiang Wolwo Bio-Pharmaceutical's Q3 Profit Rises 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477799935","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477799935?lang=en_us&edition=fundamental","pubTime":"2024-10-24 15:34","pubTimestamp":1729755284,"startTime":"0","endTime":"0","summary":"Zhejiang Wolwo Bio-Pharmaceutical's attributable profit rose 1.2% year over year to 123 million yuan in the third quarter, according to a Thursday filing with the Shenzhen Stock Exchange.Earnings per share at the drug company increased 1.3% year over year to 0.2350 yuan.Operating income grew 4.7% year over year to 301 million yuan.Shares closed 7% higher during Thursday's trading.Price : 24.97, Change: +1.7, Percent Change: +7.31%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK0239","300357"],"gpt_icon":1},{"id":"2470777124","title":"Chinese Drug Regulator Accepts Wolwo Bio-Pharmaceutical's Application to Test House Dust Mite Film","url":"https://stock-news.laohu8.com/highlight/detail?id=2470777124","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470777124?lang=en_us&edition=fundamental","pubTime":"2024-09-27 17:44","pubTimestamp":1727430255,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted Zhejiang Wolwo Bio-Pharmaceutical's clinical trial application for its house dust mite film, according to a Thursday disclosure on the Shenzhen Stock Exchange.The product will help diminish the effects of allergic rhinitis and allergic asthma caused by dust mite allergy, the pharmaceutical company.Shares of the company jumped 10% at the close.Price : 20.53, Change: +1.9, Percent Change: +10.08%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0028","300357"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-01-21","address":"浙江省湖州市德清县武康镇志远北路636号","stockEarnings":[{"period":"1week","weight":-0.031},{"period":"1month","weight":-0.041},{"period":"3month","weight":0.2281},{"period":"6month","weight":0.0071},{"period":"1year","weight":-0.2106},{"period":"ytd","weight":-0.2596}],"companyName":"浙江我武生物科技股份有限公司","boardCode":"AI0027","perCapita":"14293股","boardName":"医药制造业","registeredCapital":"52358万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 浙江我武生物科技股份有限公司是一家过敏性疾病诊断及治疗产品的研发、生产和销售的高新技术企业。公司主要产品包括粉尘螨滴剂、黄花蒿花粉变应原舌下滴剂、粉尘螨皮肤点刺诊断试剂盒、屋尘螨皮肤点刺诊断试剂盒、“黄花蒿花粉变应原皮肤点刺液”、“白桦花粉变应原皮肤点刺液”、“葎草花粉变应原皮肤点刺液”。","serverTime":1734973444616,"listedPrice":20.05,"stockholders":"33867人(较上一季度增加3.16%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.,300357,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票老虎,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票老虎国际,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.行情,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票行情,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股价,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股市,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票价格,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票交易,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票购买,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}